ArticlePharmaceutics2022

Safe and Effective Cynomolgus Monkey GLP-Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders.

Sebastian Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.